CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 161 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2016. The put-call ratio across all filers is 1.47 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,364,000 | -59.8% | 21,994 | -53.4% | 0.01% | -60.7% |
Q3 2016 | $5,881,000 | +494.6% | 47,246 | +408.0% | 0.03% | +460.0% |
Q2 2016 | $989,000 | +168.8% | 9,300 | +189.1% | 0.01% | +150.0% |
Q1 2016 | $368,000 | -11.5% | 3,217 | +10.2% | 0.00% | -33.3% |
Q4 2015 | $416,000 | +45.5% | 2,918 | -8.5% | 0.00% | +50.0% |
Q3 2015 | $286,000 | +32.4% | 3,189 | +69.9% | 0.00% | +100.0% |
Q2 2015 | $216,000 | -23.1% | 1,877 | -36.2% | 0.00% | -50.0% |
Q1 2015 | $281,000 | -46.1% | 2,940 | -74.9% | 0.00% | -71.4% |
Q2 2014 | $521,000 | – | 11,720 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ariose Capital Management Ltd | 88,655 | $10,149,000 | 9.57% |
WARBURG PINCUS LLC | 4,087,200 | $467,903,000 | 8.91% |
RUDMAN ERROL M | 64,001 | $7,327,000 | 4.96% |
INDUS CAPITAL PARTNERS, LLC | 378,518 | $43,333,000 | 4.22% |
OBERWEIS ASSET MANAGEMENT INC/ | 90,105 | $10,315,000 | 2.98% |
Ativo Capital Management LLC | 85,623 | $9,802,000 | 2.66% |
Sensato Investors LLC | 113,296 | $12,970,000 | 2.31% |
Cormorant Asset Management, LP | 111,500 | $12,765,000 | 1.92% |
BARING ASSET MANAGEMENT Ltd | 128,784 | $14,743,000 | 1.23% |
Visium Asset Management, LP | 484,619 | $55,479,000 | 0.94% |